Antacids Market

• 1. Preface
• 2. Assumptions and Research Methodology
• 3. Executive Summary: Global Market
• 4. Market Overview
• 5. Global Market Analysis and Forecasts, By Drug Class
  • 5.1. Proton Pump Inhibitors
  • 5.2. H2 Antagonist
  • 5.3. Acid Neutralizers
• 6. Global Market Analysis and Forecasts, By Formulation
  • 6.1. Tablet
  • 6.2. Liquid
  • 6.3. Powder
  • 6.4. Others
• 7. Global Market Analysis and Forecasts, By Distribution Channel
  • 7.1. Hospital Pharmacies
  • 7.2. Retail Pharmacies
  • 7.3. Others
• 8. Global Market Analysis and Forecasts, By Region
  • 8.1. North America
  • 8.2. Europe
  • 8.3. Asia Pacific
  • 8.4. Latin America
  • 8.5. Middle East and Africa
• 9. North America Market Analysis and Forecast
• 10. Europe Market Analysis and Forecast
• 11. Asia Pacific Market Analysis and Forecast
• 12. Latin America Market Analysis and Forecast
• 13. Middle East and Africa Market Analysis and Forecast
• 14. Competition Landscape
  • 14.1. AstraZeneca
  • 14.2. Bayer AG
  • 14.3. Boehringer Ingelheim GmbH
  • 14.4. Dr. Reddy’s Laboratories Ltd.
  • 14.5. GlaxoSmithKline plc
  • 14.6. Johnson & Johnson
  • 14.7. Pfizer Inc.
  • 14.8. Procter & Gamble
  • 14.9. Reckitt Benckiser Group plc
  • 14.10. Sanofi
  • 14.11. Sun Pharmaceuticals Ltd
  • 14.12. Takeda Pharmaceutical
  • 14.13. Valeant Pharmaceuticals International, Inc.

Table 01: Global Market Size (US$ Mn) Forecast, By Drug Class, 2018 to 2033

Table 02: Global Market Size (US$ Mn) Forecast, By Formulation, 2023 to 2033

Table 03: Global Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 to 2033

Table 04: Global Market (US$ Mn) Forecast, By Region, 2018 to 2033

Table 05: North America Market Size (US$ Mn) Forecast, by Drug Class, 2018 to 2033

Table 06: North America Market Size (US$ Mn) Forecast, by Formulation, 2018 to 2033

Table 07: North America Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 to 2033

Table 08: North America Market Size (US$ Mn) Forecast, by Country, 2018 to 2033

Table 09: Europe Market Size (US$ Mn) Forecast, by Drug Class, 2018 to 2033

Table 10: Europe Market Size (US$ Mn) Forecast, by Formulation, 2018 to 2033

Table 11: Europe Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 and 2033

Table 12: Europe Market Size (US$ Mn) Forecast, by Country, 2018 to 2033

Table 13: Asia Pacific Market Size (US$ Mn) Forecast, by Drug Class, 2018 to 2033

Table 14: Asia Pacific Market Size (US$ Mn) Forecast, by Formulation, 2018 to 2033

Table 15: Asia Pacific Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 and 2033

Table 16: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2018 to 2033

Table 17: Latin America Market Size (US$ Mn) Forecast, by Drug Class, 2018 to 2033

Table 18: Latin America Market Size (US$ Mn) Forecast, by Formulation, 2018 to 2033

Table 19: Latin America Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 to 2033

Table 20: Latin America Market Size (US$ Mn) Forecast, by Country, 2018 to 2033

Table 21: Middle East and Africa Market Size (US$ Mn) Forecast, by Drug Class, 2018 to 2033

Table 22: Middle East and Africa Market Size (US$ Mn) Forecast, by Formulation, 2018 to 2033

Table 23: Middle East and Africa Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 and 2033

Table 24: Middle East and Africa Market Size (US$ Mn) Forecast, by Country, 2018 to 2033

Figure 01: Global Market Size (US$ Mn) Forecast, 2018 to 2033

Figure 02: Market Value Share, By Drug Class (2022)

Figure 03: Market Value Share, By Formulation (2022)

Figure 04: Market Value Share By, Distribution Channel (2022)

Figure 05: Market Value Share, By Region (2022)

Figure 06: Porter’s Five Force Analysis

Figure 07: Global Market Value Share Analysis, By Drug Class, 2022 and 2033

Figure 08: Global Proton Pump Inhibitor Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033

Figure 09: Global H2 Antagonist Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033

Figure 10: Global Acid Neutralizer Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033

Figure 11: Market Attractiveness Analysis, By Drug Class

Figure 12: Global Market Value Share Analysis, By Formulation, 2022 and 2033

Figure 13: Global Tablet Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033

Figure 14: Global Liquids Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033

Figure 15: Global Powder Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033

Figure 16: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033

Figure 17: Global Market Attractiveness Analysis, By Formulation

Figure 18: Global Market Value Share Analysis, By Distribution Channel, 2022 and 2033

Figure 19: Global Hospital Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033

Figure 20: Global Retail Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033

Figure 21: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033

Figure 22: Global Market Attractiveness Analysis, By Distribution Channel

Figure 23: Global Market Value Share, By Region, 2022 and 2033

Figure 24: Global Market Attractiveness Analysis, By Region Type

Figure 25: North America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018 to 2033

Figure 26: North America Market Attractiveness Analysis, By Country

Figure 27: North America Market Value Share Analysis, By Drug Class, 2022 and 2033

Figure 28: North America Market Value Share Analysis, By Formulation, 2022 and 2033

Figure 29: North America Market Value Share Analysis, By Distribution Channel, 2022 and 2033

Figure 30: North America Market Value Share Analysis, By Country, 2022 and 2033

Figure 31: North America Market Attractiveness Analysis, By Drug Class

Figure 32: North America Market Attractiveness Analysis, By Formulation

Figure 33: North America Market Attractiveness Analysis, By Distribution Channel

Figure 34: Europe Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018 to 2033

Figure 35: Europe Market Attractiveness Analysis, By Country

Figure 36: Europe Market Value Share Analysis, By Drug Class, 2022 and 2033

Figure 37: Europe Market Value Share Analysis, By Formulation, 2022 and 2033

Figure 38: Europe Market Value Share Analysis, By Distribution Channel, 2022 and 2033

Figure 39: Europe Market Value Share Analysis, By Country, 2022 and 2033

Figure 40: Europe Market Attractiveness Analysis, By Drug Class

Figure 41: Europe Market Attractiveness Analysis, By Formulation

Figure 42: Europe Market Attractiveness Analysis, By Distribution Channel

Figure 43: Asia Pacific Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018 to 2033

Figure 44: Asia Pacific Market Attractiveness Analysis, By Country

Figure 45: Asia Pacific Market Value Share Analysis, By Drug Class, 2022 and 2033

Figure 46: Asia Pacific Market Value Share Analysis, By Formulation, 2022 and 2033

Figure 47: Asia Pacific Market Value Share Analysis, By Distribution Channel, 2022 and 2033

Figure 48: Asia Pacific Market Value Share Analysis, By Country, 2022 and 2033

Figure 49: Asia Pacific Market Attractiveness Analysis, By Drug Class

Figure 50: Asia Pacific Market Attractiveness Analysis, By Formulation

Figure 51: Asia Pacific Market Attractiveness Analysis, By Distribution Channel

Figure 52: Latin America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018 to 2033

Figure 53: Latin America Market Attractiveness Analysis, By Country

Figure 54: Latin America Market Value Share Analysis, By Drug Class, 2022 and 2033

Figure 55: Latin America Market Value Share Analysis, By Formulation, 2022 and 2033

Figure 56: Latin America Market Value Share Analysis, By Distribution Channel, 2022 and 2033

Figure 57: Latin America Market Value Share Analysis, By Country, 2022 and 2033

Figure 58: Latin America Market Attractiveness Analysis, By Drug Class

Figure 59: Latin America Market Attractiveness Analysis, By Formulation

Figure 60: Latin America Market Attractiveness Analysis, By Distribution Channel

Figure 61: Middle East and Africa Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018 to 2033

Figure 62: Middle East and Africa Market Attractiveness Analysis, By Country

Figure 63: Middle East and Africa Market Value Share Analysis, By Drug Class, 2022 and 2033

Figure 64: Middle East and Africa Market Value Share Analysis, By Formulation, 2022 and 2033

Figure 65: Middle East and Africa Market Value Share Analysis, By Distribution Channel, 2022 and 2033

Figure 66: Middle East and Africa Market Value Share Analysis, By Country, 2022 and 2033

Figure 67: Middle East and Africa Market Attractiveness Analysis, By Drug Class

Figure 68: Middle East and Africa Market Attractiveness Analysis, By Formulation

Figure 69: Middle East and Africa Market Attractiveness Analysis, By Distribution Channel

Figure 70: AstraZeneca, Breakdown of Net Sales (%), by Region, 2022

Figure 71: AstraZeneca, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022

Figure 72: Bayer AG, Breakdown of Net Sales (%), by Region, 2022

Figure 73: Bayer AG, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022

Figure 74: Boehringer Ingelheim, Break down of Net Sales (%), by Region, 2022

Figure 75: Boehringer Ingelheim, Revenue (US$ Mn) & Y-o-Y Growth (%), 2018 to 2022

Figure 76: Dr. Reddy’s, Breakdown of Net Sales (%), by Region, 2022

Figure 77: Dr. Reddy’s, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022

Figure 78: GlaxoSmithKline, Breakdown of Net Sales (%), by Region, 2022

Figure 79: GlaxoSmithKline, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022

Figure 80: Johnson & Johnson, Break down of Net Sales (%), by Region, 2022

Figure 81: Johnson & Johnson, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022

Figure 82: Pfizer Inc., Breakdown of Net Sales (%), by Region, 2022 (%)

Figure 83: Pfizer Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022

Figure 84: P&G, Breakdown of Net Sales (%), by Region, 2022

Figure 85: P&G, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022

Figure 86: Reckitt Benckiser, Breakdown of Net Sales (%), by Region, 2022

Figure 87: Reckitt Benckiser, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022

Figure 88: Sanofi, Breakdown of Net Sales (%), by Region, 2022

Figure 89: Sanofi, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022

Figure 90: Breakdown of Net Sales (%), by Region, 2022

Figure 91: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014 to 2022

Figure 92: Takeda Pharmaceutical, Break down of Net Sales (%), by Region, 2022

Figure 93: Takeda Pharmaceutical, Revenue (US$ Bn) & Y-o-Y Growth (%), 2018 to 2022

Figure 94: Valeant Pharmaceuticals International, Inc., Break down of Net Sales (%), by Region, 2022

Figure 95: Valeant Pharmaceuticals International, Inc., Revenue (US$ Bn) & Y-o-Y Growth (%), 2018 to 2022